ADNRX
Price
$22.87
Change
-$0.11 (-0.48%)
Updated
Jul 2 closing price
Net Assets
160.69M
RPTIX
Price
$102.00
Change
-$0.33 (-0.32%)
Updated
Jul 2 closing price
Net Assets
22.84B
Interact to see
Advertisement

ADNRX vs RPTIX

ADNRX vs RPTIX Comparison Chart in %
View a ticker or compare two or three
VS
ADNRX vs. RPTIX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RPTIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 22.8B vs. ADNRX (161M). RPTIX pays higher dividends than ADNRX: RPTIX (0.11) vs ADNRX (0.00). ADNRX was incepted earlier than RPTIX: ADNRX (6 years) vs RPTIX (11 years). ADNRX (1.18) is less costly to investors than RPTIX (0.63). ADNRX is a more actively managed with annual turnover of: 46.00 vs. RPTIX (31.50). ADNRX has a lower initial minimum investment than RPTIX: ADNRX (0) vs RPTIX (500000). ADNRX annual gain was more profitable for investors over the last year : 17.89 vs. RPTIX (0.11). RPTIX return over 5 years is better than : -18.30 vs. ADNRX (-50.80).
ADNRXRPTIXADNRX / RPTIX
Total Expense Ratio1.050.63167%
Annual Report Gross Expense Ratio1.180.63187%
Fund Existence6 years11 years-
Gain YTD7.8274.519173%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets161M22.8B1%
Annual Yield % from dividends0.000.11-
Returns for 1 year17.890.1116,140%
Returns for 3 years85.782.163,975%
Returns for 5 years-50.80-18.30278%
Returns for 10 yearsN/A37.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPFCX74.760.40
+0.54%
Davis Balanced Fund A
UGTCX31.25N/A
N/A
Victory Growth and Tax Strategy C
UIAGX79.53-0.79
-0.98%
Victory Aggressive Growth Institutional
UAPIX105.24-1.21
-1.14%
ProFunds UltraSmall Cap Inv
DEMRX64.89-5.64
-8.00%
Nomura Emerging Markets R